Ajinomoto Bio-Pharma Services

Meet with our team in London! Members of the Ajinomoto Bio-Pharma Services team will be attending the NextGen Biomed conference at the Novotel London West, UK, March 12-14. Tomohiro Fujii, Ph.D., will be giving a presentation on “A Versatile Approach to Generating Next-Generation Antibody Conjugates Through AJICAP? Technologies” on March 13 at 12 pm. You can also connect with our team by stopping by booth 63, or by scheduling a meeting. Learn more about this conference here: https://hubs.li/Q038MDBk0

Leadership Announcement: A New Chapter for Ajinomoto Bio-Pharma Services, U.S. We are excited to share a leadership transition at Ajinomoto Bio-Pharma Services, U.S. After an incredible career, Bert Barbosa has decided to retire as President & COO. We extend our deepest gratitude for his 6.5 years of dedicated leadership at our San Diego site and over 40 years of impact in the Bio-Pharma industry. Stepping into the role of President & COO, effective February 4, is Brian Blagg, formerly our Executive Vice President of Operations. With 34 years of cross-functional leadership experience—23 in the biopharmaceutical industry—Brian is a proven leader dedicated to operational excellence and serving patients in need Please join us in celebrating Bert’s remarkable career and congratulating Brian as he leads us into this next chapter of growth!

Don’t miss Tsubasa Aoki, Ph.D. at TIDES Asia Oligonucleotide & Peptide Therapeutics! Dr. Aoki will be presenting on Pioneering the Development of Highly Stable Site-Specific Antibody-Oligonucleotide Conjugates (AOC) Using Fc-Targeting Reagents at TIDES Asia Oligonucleotide & Peptide Therapeutics February 27th at 4:15 pm at the Westin Miyako in Kyoto, Japan. We are also exhibiting at booth 23, so please stop by and meet our team. Learn more about this session and conference here: https://hubs.li/Q038r_pP0

?? Coming next month in the Big Apple! DCAT is just 3 weeks away, don’t miss this opportunity to connect with our team at this great conference. Plan a meeting with our team here: https://hubs.li/Q038cTW30

Coming next month, Tomohiro Fujii will be presenting at the 15th annual World ADC 2025 meeting. Mr. Fujii will be giving a presentation covering A Versatile Approach to Generating Next-Generation Antibody Conjugates Through AJICAP? Technologies. Here are the full details: ?? March 4th ? 9:00 am ?? London, UK Learn more about the conference here: https://hubs.ly/Q037Z4t80

Don’t miss Tsubasa Aoki, Ph.D. at TIDES Asia Oligonucleotide & Peptide Therapeutics next week! Dr. Aoki will be presenting on Pioneering the Development of Highly Stable Site-Specific Antibody-Oligonucleotide Conjugates (AOC) Using Fc-Targeting Reagents at TIDES Asia Oligonucleotide & Peptide Therapeutics February 27th at 4:15 pm at the Westin Miyako in Kyoto, Japan. Learn more about this session and conference here: https://bit.ly/3Xcq0f6

Next week Joris De Keijser, Strategic Marketing Manager, will be facilitating a panel to discuss with our common challenge in pharma to structurally evolve to Net Zero. Addressing questions such as, What is pharma’s impact on global scale? What is the current status in the number of SBTI validated net zero targets by pharma companies and why? What are actual strategies to speed up today’s manufacturing impact? Join the public debate with the panelists and attendees here: https://bit.ly/4i2zamq Learn more about Ajinomoto Omnichem here: https://bit.ly/4jWRNd4

Thank you to everyone who engaged with us at Peptalk! Earlier this month, the Ajinomoto Bio-Pharma Services Japan team was happy to participate during this conference where Hayato Nagano, PhD, presented on "Corynex??: Microbial production platform suitable for peptides and VHHs." Our Key Platform Technologies: https://hubs.li/Q034tnnz0

Join us at DCAT 2025 in New York! Plan a meeting with our team here: https://hubs.li/Q034kssK0

Are you confident in your Fill/Finish partner selection process? The Aseptic Fill/Finish stage is a critical final step in drug manufacturing, directly impacting patient safety and product success. Join Ramon Gonzalez, Manager, Drug Product Manufacturing, Ajinomoto Bio-Pharma Services and Outsourced Pharma for a discussion on: ? Minimizing risk while maximizing yield ? Ensuring quality through strategic partnerships ? Why experience matters in therapeutic delivery ?? Learn the four essential questions to ask when evaluating #FillFinish providers. February 12th, 2025 11:00 EST ?? Don’t miss it! Register now: https://hubs.li/Q033Lr-D0) #biopharma #manufacturing #outsourcing #FillFinish #Ajibiopharma